EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol

Ondrej Fabian iD, Lukas Bajer, Peter Macinga, Jan Brezina, Mojmir Hlavaty, Pavel Drastich, Pavel Wohl, Karel Harant, Pavel Talacko, Eva Sticova, Andrea Vajsova iD, Alena Bohdanecka iD und 2 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0341885 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2026. Verfasst von Ondrej Fabian und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Hauptthemen laut MEDLINE: Biomarkers, Proteomics, Colitis, Ulcerative, Cholangitis, Sclerosing. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBD) and primary sclerosing cholangitis (PSC) are chronic inflammatory conditions with limited biomarker-driven diagnostic tools. Proteomic profiling offers a promising approach to uncover specific biomarkers that could refine diagnostic accuracy, monitor disease activity, and guide therapeutic strategies. Our primary aim is to identify novel biomarkers for PSC-IBD and conventional ulcerative colitis (UC) via proteomic approach. The secondary aim is to advance the etiopathogenic understanding of the diseases by linking specific proteomic profiles with disease phenotypes. This single-center, prospective, biomarker-discovery study will involve 50 participants with PSC-IBD, 50 with UC, and 50 healthy controls. Biopsy samples from five bowel segments will be analyzed for proteomic signatures by an untargeted approach. The findings will subsequently undergo multi-step external validation in separate cohorts of 30 patients with PSC-IBD and 30 with UC, utilizing targeted proteomics, immunohistochemistry, and ELISA in bowel mucosa and peripheral blood, respectively. This proposed study aims to identify novel biomarkers to improve the diagnostic accuracy of PSC-IBD and UC and refine the disease activity assessment. Its robust design and large sample size provide a strong foundation for successful biomarker identification, with the potential to enhance clinical management of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersProteomicsColitis, UlcerativeCholangitis, SclerosingInflammatory Bowel DiseasesHumansProspective StudiesFemaleIntestinal MucosaMaleCase-Control StudiesAdult

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Department of Pathology and Molecular Medicine, Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
  • Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Department of Internal Medicine, Motol University Hospital and Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Proteomics Core Facility, Faculty of Science, Charles University, Vestec, Czech Republic.
  • Department of Pathology, Royal Vinohrady University Hospital, Srobarova, Prague, Czech Republic.

ORCID-Profile: Ondrej Fabian, Andrea Vajsova, Alena Bohdanecka

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky

Zitieren

APA

Fabian, O., Bajer, L., Macinga, P., Brezina, J., Hlavaty, M., Drastich, P., Wohl, P., Harant, K., Talacko, P., Sticova, E., Vajsova, A., Bohdanecka, A., Tichanek, F., & Cahova, M. (2026). Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol. PLOS One. https://doi.org/10.1371/journal.pone.0341885

Vancouver

Fabian O, Bajer L, Macinga P, Brezina J, Hlavaty M, Drastich P, et al. Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol. PLOS One. 2026. doi:10.1371/journal.pone.0341885

BibTeX
@article{Fabian2026,
  author = {Fabian, Ondrej and Bajer, Lukas and Macinga, Peter and Brezina, Jan and Hlavaty, Mojmir and Drastich, Pavel and Wohl, Pavel and Harant, Karel and Talacko, Pavel and Sticova, Eva and Vajsova, Andrea and Bohdanecka, Alena and Tichanek, Filip and Cahova, Monika},
  title = {Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0341885}
}
Kostenlos starten →